Evidence map›Paper›PMID 40508678›Full record

ArticlePolymers2025

The Use of Bio-Polyurethane Binder for the Development of Engineered Wood Composites.

Sigitas Vėjelis, Agnė Kairytė, Saulius Vaitkus, Arūnas Kremensas

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sigitas VėjelisBuilding Materials Institute, Faculty of Civil Engineering, Vilnius Gediminas Technical University, Linkmenu Str. 28, LT-08217 Vilnius, Lithuania.ORCID 0000-0001-9657-599X
Agnė KairytėBuilding Materials Institute, Faculty of Civil Engineering, Vilnius Gediminas Technical University, Linkmenu Str. 28, LT-08217 Vilnius, Lithuania.ORCID 0000-0003-4239-0871
Saulius VaitkusBuilding Materials Institute, Faculty of Civil Engineering, Vilnius Gediminas Technical University, Linkmenu Str. 28, LT-08217 Vilnius, Lithuania.ORCID 0000-0002-4587-6597
Arūnas KremensasBuilding Materials Institute, Faculty of Civil Engineering, Vilnius Gediminas Technical University, Linkmenu Str. 28, LT-08217 Vilnius, Lithuania.ORCID 0000-0003-1194-0455

Funding

Research Council of Lithuania (LMTLT) S-MIP-23-121
6 · The paper itself

Abstract

Fiber hemp shives and biopolyurethane binder were used to create an engineered wood composite due to the synergistic properties of these materials. This study created engineered wood specimens using different ratios of biopolyurethane binder and hemp shives, which varied from 0.5 to 1.5. Different pressure levels were used when preparing the specimens, which were 1.5, 3.0, and 4.5 MPa. The formed engineered wood specimens showed that both the amount of binder and the level of pressure significantly influence the strength and moisture indicators, and different processes occur when increasing the amount of binder and the level of pressure. The research showed that the developed engineered wood composites had reached bending strength equal to 17 MPa, tensile strength equal to 7 MPa, and compressive stress equal to 11 MPa. In most cases, the strength index values were higher than those of various industrial-engineered wood products. Engineered wood was characterized by water absorption from 35 to 10%, and swelling in water varied from 26 to 10%. The flammability of the specimens, determined by the low-flame method, indicated that the specimens were flammable, but the expanded graphite used allowed for the creation of non-flammable specimens.

Indexed as

biopolyurethaneengineered wood compositehemp shivesmechanical propertiesreaction to fireshort-term water absorption

Identifiers

PMID40508678
PMCPMC12156973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.